Senior Product Manager/Product Manager at Bristol-Myers Squibb

Shanghai, China

Bristol-Myers Squibb Logo
Not SpecifiedCompensation
Senior (5 to 8 years), Mid-level (3 to 4 years)Experience Level
Full TimeJob Type
UnknownVisa
Pharmaceuticals, Biotechnology, HealthcareIndustries

Requirements

  • (Not explicitly listed in the provided job description)

Responsibilities

  • Leverages competitive analyses to identify market trends, customer needs and opportunities for differentiation
  • Plans in-depth market intelligence analysis to support business growth requirements and new opportunities development
  • Monitors and analyzes product performance and makes recommendations for improvements or changes
  • Ensures alignment of product marketing activities with corporate branding and messaging guidelines
  • Helps manage commercial strategy for dedicated products' brand planning process and executes marketing activities associated with brand plans
  • Supports sales teams with sales tools and messaging support

Skills

Product Management
Competitive Analysis
Market Intelligence
Product Performance Analysis
Brand Planning
Commercial Strategy
Marketing Activities
Sales Tools
Messaging Support

Bristol-Myers Squibb

Develops and delivers biopharmaceutical medicines

About Bristol-Myers Squibb

Bristol Myers Squibb (BMS) develops and delivers medicines aimed at treating serious diseases, focusing on areas like cancer, autoimmune diseases, and heart conditions. The company conducts extensive research and development to create new drugs, which are sold after receiving regulatory approval. BMS also produces generic drugs, offering affordable alternatives that meet the same quality standards as their branded counterparts. What sets BMS apart from competitors is its dual focus on both innovative and generic medicines, enhancing access to healthcare. The company's goal is to improve patient outcomes while maintaining a commitment to sustainability and corporate responsibility.

New York City, New YorkHeadquarters
1887Year Founded
$33,706.1MTotal Funding
IPOCompany Stage
Biotechnology, HealthcareIndustries
10,001+Employees

Benefits

Flexible Work Hours
Hybrid Work Options
Professional Development Budget

Risks

Increased competition in oncology from emerging biotech firms like ArsenalBio.
BMS's lawsuit over the 340B Drug Pricing Program may lead to regulatory challenges.
Rapid AI and digital tech evolution may pose integration challenges for BMS.

Differentiation

BMS focuses on innovative cancer treatments through collaborations like ArsenalBio for T cell therapies.
The company emphasizes digital health technologies, enhancing clinical trial management and patient engagement.
BMS offers both innovative and generic medicines, increasing affordable healthcare solutions.

Upsides

BMS's partnership with Medidata enhances clinical research processes and patient outcomes.
The collaboration with AI Proteins advances novel miniprotein-based therapeutics, expanding therapeutic modalities.
BMS's global license agreement with BioArctic expands its portfolio in neurodegenerative diseases.

Land your dream remote job 3x faster with AI